Back to Search
Start Over
Docetaxel-induced acute myositis: a case report with review of literature
- Source :
- Journal of chemotherapy (Florence, Italy). 33(2)
- Publication Year :
- 2020
-
Abstract
- Docetaxel is an anti-microtubule agent and a highly effective treatment of locally advanced and metastatic breast cancer. There are several adverse effects associated with docetaxel, such as myelosuppression, peripheral neuropathy, fluid retention, and asthenia. One of the most well-known side-effects of this medication is mild to moderate myalgia. Here, we report a case of a 49-year-old female with stage 3 breast cancers who developed severe acute myositis following docetaxel use. The mechanism of docetaxel-induced myositis remains unclear; however, physicians still need to be aware of the possibility of this complication in patients with cancer and a history of exposure to this medication.
- Subjects :
- 0301 basic medicine
Oncology
myalgia
medicine.medical_specialty
medicine.medical_treatment
030106 microbiology
Antineoplastic Agents
Breast Neoplasms
Docetaxel
03 medical and health sciences
0302 clinical medicine
Internal medicine
medicine
Humans
Pharmacology (medical)
Adverse effect
Myositis
Pharmacology
Chemotherapy
business.industry
Cancer
Middle Aged
medicine.disease
Metastatic breast cancer
Infectious Diseases
Peripheral neuropathy
030220 oncology & carcinogenesis
Female
medicine.symptom
business
medicine.drug
Subjects
Details
- ISSN :
- 19739478
- Volume :
- 33
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Journal of chemotherapy (Florence, Italy)
- Accession number :
- edsair.doi.dedup.....36752ed6a91fbdce3401766b508f7ce1